Sionna Therapeutics Launches with $111 Million Series B Financing …
Sionna Therapeutics is led by industry veteranswith deep experience in CF and rare disease drug development and commercialization, including: 1. Mike Cloonan, President and Chief Executive OfficerMr. Cloonan brings two decades of biopharma leadership experience including his most recent experience as the … See more
OFF
Sionna Therapeutics Launches With $111 Million Series B Financing …
1 week from now
Sionna Therapeutics is led by industry veteranswith deep experience in CF and rare disease drug development and commercialization, including: 1. Mike Cloonan, President and Chief Executive OfficerMr. Cloonan brings two decades of biopharma leadership experience including his most recent experience as the … See more
sionnatx.com
OFF
Sionna Therapeutics Launches With $111 Million Series B Financing …
1 week from now
BOSTON, April 19, 2022 /PRNewswire/ -- Sionna Therapeutics, a life sciences company founded in 2019 to develop highly effective and differentiated treatments for cystic fibrosis (CF), today ...
prnewswire.com
OFF
Sionna Unveils With $111M Series B To Pursue Quest For 'holy Grail ...
1 week from now
Apr 19, 2022 · After spending more than two years in stealth mode, Sionna Therapeutics is unveiling with $111 million in series B funds to catapult its cystic fibrosis pipeline and take on …
fiercebiotech.com
OFF
Fueled By $111 Million, Sionna Therapeutics Takes Aim At
1 week from now
Apr 19, 2022 · Sionna is making its public debut with $111 million in Series B financing that will support the development of its assets aimed at stabilizing CFTR's first nucleotide-binding …
biospace.com
OFF
Sionna Launches With $111 Million To Advance Small Molecules …
1 week from now
Apr 19, 2022 · Sionna Launches with $111 Million to Advance Small Molecules with Potential to Restore CFTR Function in Cystic Fibrosis. April 19, 2022. Rare Daily Staff. Sionna …
globalgenes.org
OFF
Sionna Emerges For Cystic Fibrosis Drugs | C&EN Global Enterprise
1 week from now
Apr 25, 2022 · Sionna Therapeutics has officially launched with the closing of a $111 million series B funding. The Boston-based firm was founded in 2019 to develop small molecules that …
acs.org
OFF
Sionna Therapeutics Launches With $111 Million Series B Financing
1 week from now
Apr 19, 2022 · Sionna Therapeutics, a life sciences company founded in 2019 to develop highly effective and differentiated treatments for cystic fibrosis (CF), today announced the official …
citybiz.co
OFF
OrbiMed Leads $111M Series B Round For Sionna
1 week from now
Apr 20, 2022 · Life sciences firm Sionna Therapeutics Inc. raised $111 million in a series B financing round led by OrbiMed Advisors LLC. Other participants in the round included funds …
spglobal.com
OFF
Sionna Therapeutics Launches With $111 Million Series B Financing
1 week from now
20 April 2022. Boston, USA-based Sionna Therapeutics, a life sciences company founded in 2019 to develop highly effective and differentiated treatments for cystic fibrosis (CF), has announced …
thepharmaletter.com
OFF
Fueled By $111 Million, Sionna Therapeutics Takes Aim At
1 week from now
Apr 19, 2022 · Sionna is making its public debut with $111 million in Series B financing that will support the development of its assets aimed at stabilizing CFTR’s first nucleotide-binding …
biospace.com
OFF
Sionna Therapeutics Raises $111M In Series B Financing
1 week from now
April 21, 2022. Sionna Therapeutics, a Boston, MA-based life sciences company developing differentiated treatments for cystic fibrosis (CF), closed a $111m Series B financing. The round …
finsmes.com
OFF
Sionna Launches For Cystic Fibrosis Drugs - Chemical & Engineering …
1 week from now
Apr 23, 2022 · Sionna Therapeutics has officially launched with the closing of a $111 million series B funding. The Boston-based firm was founded in 2019 to develop small molecules that …
acs.org
OFF
Series B - Sionna Therapeutics - 2022-04-19 - Crunchbase
1 week from now
News • Apr 19, 2022. PR Newswire — Sionna Therapeutics Launches with $111 Million Series B Financing to Advance Pipeline of Novel Small Molecules with the Potential to Fully Restore …
crunchbase.com
OFF
Sionna Adds $182M To Extend Pipeline, Cash Runway Through 2026
1 week from now
Mar 6, 2024 · Sionna CEO Mike Cloonan said the company's series C will be its last private financing. Sionna Therapeutics has closed a $182 million series C, enough to last through …
fiercebiotech.com
OFF
Sionna Therapeutics Launches With $111 Million Series B Financing …
1 week from now
BOSTON, April 19, 2022 /PRNewswire/ -- Sionna Therapeutics, a life sciences company founded in 2019 to develop highly effective and differentiated treatments for cystic fibrosis (CF), today …
biospace.com
OFF
Sionna Therapeutics Launches With $111 Million Series B Financing …
1 week from now
Apr 19, 2022 · Sionna Therapeutics today announced the official launch of the company and the closing of a $111 million Series B financing. Sionna Therapeutics Launches with $111 Million …
biospace.com
FAQs about Sionna Therapeutics Launches with $111 Million Series B Financing … Coupon?
What is Sionna Therapeutics?
What is Sionna Therapeutics doing with $111 million in Series B funds?
Is Sionna 109 the best combination asset?
Is Sionna chasing vertex in the cystic fibrosis market?
How much money has Sionna raised?
Is Sionna a good investment?
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
